Loading...

Oral Vaccine Platform And Norovirus Opportunity Will Drive Long Term Upside Potential

Published
15 Dec 25
Views
0
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-37.4%
7D
1.3%

Author's Valuation

US$3.3388.9% undervalued intrinsic discount

AnalystConsensusTarget Fair Value